Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120677 · ClinicalTrials.gov registry record · Early Phase 1
Topical Itraconazole in the Treatment of Basal Cell Carcinoma
A Early Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT02120677: Completed Early Phase 1 study, sponsored by Johns Hopkins University.
NCT02120677 is a Early Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02120677, a Early Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research is being done to study the molecular effects of topically applied itraconazole ointment on the growth of basal cell carcinomas.
Interventions
- DRUG Itraconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-05 |
| Est. Completion | 2019-01-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02120677
The ClinicalTrials.gov registry entry for NCT02120677 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Itraconazole is the first listed.
NCT02120677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02120677 about?
NCT02120677 is a clinical study titled "Topical Itraconazole in the Treatment of Basal Cell Carcinoma". This research is being done to study the molecular effects of topically applied itraconazole ointment on the growth of basal cell carcinomas.
What is the current status of trial NCT02120677?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2014-05. Estimated completion is 2019-01-30.
What interventions are being tested in trial NCT02120677?
The interventions under investigation include: Itraconazole (DRUG).
Who is sponsoring clinical trial NCT02120677?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.